---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-010740"
form_type: "8-K"
ticker: "HROW"
cik: "0001360214"
company_name: "HARROW, INC."
filed_at: "2024-03-21T23:59:59+00:00"
generated_at: "2026-06-04T09:43:08.215712+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CMS increases MUE for Harrow's IHEEZO J-Code from 1 to 2, effective July 2024 retroactive to Jan 1, 2024

## Summary
- CMS approved increase of Medically Unlikely Edit (MUE) for IHEEZO J-Code J2403 from 1 to 2 units.
- Change allows billing for two vials of IHEEZO, supporting bilateral ocular procedures.
- Effective July 2024, with retroactive application to procedures from January 1, 2024.
- Company requested the change in February 2024 citing ophthalmologist need for bilateral use.

## SEC filing metadata
- accession: 0001493152-24-010740
- form_type: 8-K
- ticker: HROW
- cik: 0001360214
- company_name: HARROW, INC.
- filed_at: 2024-03-21T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1360214/000149315224010740/0001493152-24-010740-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1360214/000149315224010740/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-010740
- JSON: https://secwatch.observer/filing/0001493152-24-010740.json
- Plain text: https://secwatch.observer/filing/0001493152-24-010740.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.